On April 26th Michel Bracké was elected into the board of Directors of Strax AB, a listed company on OMX Nasdaq, Stockholm.
STRAX is the global specialist for mobile accessories, connected devices and innovative customer solutions.
As of January 1st 2014, Michel Bracké, will assume the role of CEO for Nicoccino. Nicoccino is a spin off company from FFT Medical AB.
Since July 2013, Michel Bracké has assumed the role of CEO under a consultancy contract. During this period the strategy, product name and positioning were defined helping the company in a new capitalization round.
The focus now will be to launch Nicoccino, a powerful pure nicotine product for smokers and vapers, in the United Kingdom during 2014. Nicoccino is also planning a listing on Nasdaq OMX First North later this spring.